-
1
-
-
77449159028
-
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
-
PID: 19880497
-
Döhner H, Estey EH, Amadori S et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453–474
-
(2010)
Blood
, vol.115
, pp. 453-474
-
-
Döhner, H.1
Estey, E.H.2
Amadori, S.3
-
2
-
-
33751267902
-
Acute myeloid leukaemia
-
PID: 17126723
-
Estey E, Döhner H (2006) Acute myeloid leukaemia. Lancet 368:1894–1907
-
(2006)
Lancet
, vol.368
, pp. 1894-1907
-
-
Estey, E.1
Döhner, H.2
-
4
-
-
0032188805
-
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial
-
COI: 1:CAS:528:DyaK1cXmsVKnsrw%3D, PID: 9746770
-
Grimwade D, Walker H, Oliver F et al (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92:2322–2333
-
(1998)
Blood
, vol.92
, pp. 2322-2333
-
-
Grimwade, D.1
Walker, H.2
Oliver, F.3
-
5
-
-
0028898585
-
Immunologic effects of blood transfusion
-
COI: 1:STN:280:DyaK2M3ivFagug%3D%3D, PID: 7713588
-
Tartter PI (1995) Immunologic effects of blood transfusion. Immunol Invest 24:277–288
-
(1995)
Immunol Invest
, vol.24
, pp. 277-288
-
-
Tartter, P.I.1
-
6
-
-
0026504855
-
Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system
-
COI: 1:STN:280:DyaK387jvF2gtA%3D%3D, PID: 1736014
-
Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W (1992) Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6:52–59
-
(1992)
Leukemia
, vol.6
, pp. 52-59
-
-
Aul, C.1
Gattermann, N.2
Heyll, A.3
Germing, U.4
Derigs, G.5
Schneider, W.6
-
7
-
-
34548219420
-
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
-
PID: 17687155
-
Malcovati L, Germing U, Kuendgen A et al (2007) Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25:3503–3510
-
(2007)
J Clin Oncol
, vol.25
, pp. 3503-3510
-
-
Malcovati, L.1
Germing, U.2
Kuendgen, A.3
-
8
-
-
77954658029
-
WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL, and IDH mutations
-
COI: 1:CAS:528:DC%2BC3cXovFKmsL4%3D, PID: 20485371
-
Patnaik MM, Lasho TL, Finke CM et al (2010) WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL, and IDH mutations. Leukemia 24:1283–1289
-
(2010)
Leukemia
, vol.24
, pp. 1283-1289
-
-
Patnaik, M.M.1
Lasho, T.L.2
Finke, C.M.3
-
9
-
-
79951888693
-
Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support
-
PID: 21328437
-
Pereira A, Nomdedeu M, Aguilar JL et al (2011) Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support. Am J Hematol 86:245–250
-
(2011)
Am J Hematol
, vol.86
, pp. 245-250
-
-
Pereira, A.1
Nomdedeu, M.2
Aguilar, J.L.3
-
10
-
-
78650973404
-
Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis
-
PID: 21193428
-
Pardanani A, Tefferi A (2011) Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis. Haematologica 96:8–10
-
(2011)
Haematologica
, vol.96
, pp. 8-10
-
-
Pardanani, A.1
Tefferi, A.2
-
11
-
-
63849328927
-
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
-
COI: 1:CAS:528:DC%2BD1MXktFWnsLc%3D, PID: 18988864
-
Cervantes F, Dupriez B, Pereira A et al (2009) New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood 113:2895–2901
-
(2009)
Blood
, vol.113
, pp. 2895-2901
-
-
Cervantes, F.1
Dupriez, B.2
Pereira, A.3
-
12
-
-
84904339077
-
Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia
-
Le Jeune C, Bertoli S, Elhamri M et al (2014) Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia. Leuk Lymph 55:855–862
-
(2014)
Leuk Lymph
, vol.55
, pp. 855-862
-
-
Le Jeune, C.1
Bertoli, S.2
Elhamri, M.3
-
13
-
-
84555206702
-
Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making?
-
COI: 1:CAS:528:DC%2BC3MXhtlGrt77J
-
Thomas X, Chelghoum Y, Cannas G et al (2011) Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making? Clin Lymph Myel Leuk 11:342–349
-
(2011)
Clin Lymph Myel Leuk
, vol.11
, pp. 342-349
-
-
Thomas, X.1
Chelghoum, Y.2
Cannas, G.3
-
14
-
-
1542753559
-
Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
-
PID: 14673054
-
Cheson BD, Bennett JM, Kopecky KJ et al (2003) Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 21:4642–4649
-
(2003)
J Clin Oncol
, vol.21
, pp. 4642-4649
-
-
Cheson, B.D.1
Bennett, J.M.2
Kopecky, K.J.3
-
15
-
-
79958858626
-
Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia?
-
PID: 21671359
-
Jaime-Perez JC, Colunga-Pedraza PR, Gomez-Almaguer DG (2011) Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia? Pediatr Blood Cancer 57:217–223
-
(2011)
Pediatr Blood Cancer
, vol.57
, pp. 217-223
-
-
Jaime-Perez, J.C.1
Colunga-Pedraza, P.R.2
Gomez-Almaguer, D.G.3
-
16
-
-
0028283987
-
Transfusions and risk of failure in childhood acute lymphoblastic leukemia
-
COI: 1:STN:280:DyaK2czgvFejug%3D%3D, PID: 8035615
-
Freiberg A, Hancock M, Kunkel K (1994) Transfusions and risk of failure in childhood acute lymphoblastic leukemia. Leukemia 8:1220–1223
-
(1994)
Leukemia
, vol.8
, pp. 1220-1223
-
-
Freiberg, A.1
Hancock, M.2
Kunkel, K.3
-
17
-
-
32144431895
-
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
-
PID: 16186598
-
Malcovati L, Porta MG, Pascutto C et al (2005) Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 23:7594–7603
-
(2005)
J Clin Oncol
, vol.23
, pp. 7594-7603
-
-
Malcovati, L.1
Porta, M.G.2
Pascutto, C.3
-
18
-
-
53149113768
-
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
-
COI: 1:CAS:528:DC%2BD1cXhtFyls7rM, PID: 18618511
-
Kantarjian H, O’Brien S, Ravandi F et al (2008) Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 113:1351–1361
-
(2008)
Cancer
, vol.113
, pp. 1351-1361
-
-
Kantarjian, H.1
O’Brien, S.2
Ravandi, F.3
-
19
-
-
74049158614
-
Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis—prognostic relevance is dependent of IPSS or karyotype
-
Tefferi A, Siragusa S, Hussein K et al (2009) Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis—prognostic relevance is dependent of IPSS or karyotype. Am J Hematol 85:14–17
-
(2009)
Am J Hematol
, vol.85
, pp. 14-17
-
-
Tefferi, A.1
Siragusa, S.2
Hussein, K.3
-
20
-
-
78650989990
-
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of International Prognostic Scoring System and Dynamic International Prognostic Scoring System
-
PID: 20884708
-
Elena C, Passamonti F, Rumi E et al (2011) Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of International Prognostic Scoring System and Dynamic International Prognostic Scoring System. Haematologica 96:167–170
-
(2011)
Haematologica
, vol.96
, pp. 167-170
-
-
Elena, C.1
Passamonti, F.2
Rumi, E.3
-
21
-
-
77950352432
-
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
-
COI: 1:CAS:528:DC%2BC3cXjtlGisL4%3D, PID: 20008785
-
Passamonti F, Cervantes F, Vannucchi AM et al (2010) A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 115:1703–1708
-
(2010)
Blood
, vol.115
, pp. 1703-1708
-
-
Passamonti, F.1
Cervantes, F.2
Vannucchi, A.M.3
-
22
-
-
49149112388
-
Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts
-
COI: 1:CAS:528:DC%2BD1cXhtVGls7jN, PID: 18442062
-
Chee CE, Steensma DP, Wu W, Hanson CA, Tefferi A (2008) Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts. Am J Hematol 83:611–613
-
(2008)
Am J Hematol
, vol.83
, pp. 611-613
-
-
Chee, C.E.1
Steensma, D.P.2
Wu, W.3
Hanson, C.A.4
Tefferi, A.5
-
23
-
-
65649110882
-
Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not
-
COI: 1:CAS:528:DC%2BD1MXmtFelsrg%3D, PID: 19396855
-
Tefferi A, Mesa RA, Pardanani A et al (2009) Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not. Am J Hematol 84:265–267
-
(2009)
Am J Hematol
, vol.84
, pp. 265-267
-
-
Tefferi, A.1
Mesa, R.A.2
Pardanani, A.3
-
24
-
-
34848892687
-
Transfusion-related immunomodulation (TRIM): an update
-
PID: 17804128
-
Vamvakas EC, Blajchman MA (2007) Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21:327–348
-
(2007)
Blood Rev
, vol.21
, pp. 327-348
-
-
Vamvakas, E.C.1
Blajchman, M.A.2
-
25
-
-
0033642420
-
Immunomodulation by blood transfusions
-
PID: 10938968
-
Roelen DL, van Rood JJ, Brand A et al (2000) Immunomodulation by blood transfusions. Vox Sang 78:273–275
-
(2000)
Vox Sang
, vol.78
, pp. 273-275
-
-
Roelen, D.L.1
van Rood, J.J.2
Brand, A.3
-
26
-
-
0027968516
-
Biologic effects of leukocytes present in transfused cellular blood products
-
COI: 1:STN:280:DyaK2czmt1aitQ%3D%3D, PID: 8080981
-
Bordin JO, Heddle NM, Blajchman MA (1994) Biologic effects of leukocytes present in transfused cellular blood products. Blood 84:1703–1721
-
(1994)
Blood
, vol.84
, pp. 1703-1721
-
-
Bordin, J.O.1
Heddle, N.M.2
Blajchman, M.A.3
-
27
-
-
0035434162
-
Arginase release from red blood cells: possible link in transfusion induced immune suppression?
-
COI: 1:STN:280:DC%2BD3MvmtlOisA%3D%3D, PID: 11508862
-
Prins HA, Houdijk AP, Nijveldt RJ et al (2001) Arginase release from red blood cells: possible link in transfusion induced immune suppression? Shock 16:113–115
-
(2001)
Shock
, vol.16
, pp. 113-115
-
-
Prins, H.A.1
Houdijk, A.P.2
Nijveldt, R.J.3
-
28
-
-
62349142604
-
An introduction to chemokines and their roles in transfusion medicine
-
COI: 1:CAS:528:DC%2BD1MXkvVKisLg%3D, PID: 19076338
-
Davenport RD (2009) An introduction to chemokines and their roles in transfusion medicine. Vox Sang 96:183–198
-
(2009)
Vox Sang
, vol.96
, pp. 183-198
-
-
Davenport, R.D.1
-
29
-
-
33746492285
-
Release of potential immunomodulatory factors during platelet storage
-
COI: 1:CAS:528:DC%2BD28XnsFarur4%3D, PID: 16836566
-
Cognasse F, Boussoulade F, Chavarin P et al (2006) Release of potential immunomodulatory factors during platelet storage. Transfusion 46:1184–1189
-
(2006)
Transfusion
, vol.46
, pp. 1184-1189
-
-
Cognasse, F.1
Boussoulade, F.2
Chavarin, P.3
-
30
-
-
0029920586
-
Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays
-
COI: 1:CAS:528:DyaK28XjtVyksbk%3D, PID: 8611466
-
Wadhwa M, Seghatchian MJ, Lubenko A et al (1996) Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Haematol 93:225–234
-
(1996)
Br J Haematol
, vol.93
, pp. 225-234
-
-
Wadhwa, M.1
Seghatchian, M.J.2
Lubenko, A.3
-
31
-
-
0031753239
-
Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions
-
COI: 1:CAS:528:DyaK1cXnvFOisb0%3D, PID: 9827918
-
Edvardsen L, Taaning E, Mynster T, Hvolris J, Drachman O, Nielsen HJ (1998) Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions. Br J Haematol 103:445–448
-
(1998)
Br J Haematol
, vol.103
, pp. 445-448
-
-
Edvardsen, L.1
Taaning, E.2
Mynster, T.3
Hvolris, J.4
Drachman, O.5
Nielsen, H.J.6
-
32
-
-
0036841640
-
CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts
-
COI: 1:CAS:528:DC%2BD38XosFCjsrY%3D, PID: 12423681
-
Aldinucci D, Poletto D, Nanni P et al (2002) CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts. Exp Hematol 30:1283–1292
-
(2002)
Exp Hematol
, vol.30
, pp. 1283-1292
-
-
Aldinucci, D.1
Poletto, D.2
Nanni, P.3
-
33
-
-
0033861859
-
T-cell subsets (Th1 versus Th2)
-
COI: 1:CAS:528:DC%2BD3cXlvVSkur4%3D, PID: 10923599
-
Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85:9–18
-
(2000)
Ann Allergy Asthma Immunol
, vol.85
, pp. 9-18
-
-
Romagnani, S.1
-
34
-
-
84891493506
-
The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression
-
COI: 1:CAS:528:DC%2BC3sXhvFelsr7K, PID: 24242818
-
Komanduri KV, Wieder ED, Benjamin CL, Levy RB (2013) The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression. Immunol Res 57:140–150
-
(2013)
Immunol Res
, vol.57
, pp. 140-150
-
-
Komanduri, K.V.1
Wieder, E.D.2
Benjamin, C.L.3
Levy, R.B.4
-
35
-
-
84887817115
-
Clinical strategies to enhance thymic recovery after allogeneic hematopoietic stem cell transplantation
-
COI: 1:CAS:528:DC%2BC3sXhs12lsbnK
-
Velardi E, Dudakov JA, van den Brink MR (2013) Clinical strategies to enhance thymic recovery after allogeneic hematopoietic stem cell transplantation. Immunol Let 155:31–35
-
(2013)
Immunol Let
, vol.155
, pp. 31-35
-
-
Velardi, E.1
Dudakov, J.A.2
van den Brink, M.R.3
-
36
-
-
23844525447
-
Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt
-
PID: 16086785, discussion 39S-40S
-
Blumberg N (2005) Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 45:33S–39S, discussion 39S-40S
-
(2005)
Transfusion
, vol.45
, pp. 33-39
-
-
Blumberg, N.1
-
37
-
-
0030060765
-
Blood transfusion-induced immunomodulation
-
COI: 1:CAS:528:DyaK28XhtFGkurc%3D, PID: 8712400
-
Landers DF, Hill GE, Wong KC et al (1996) Blood transfusion-induced immunomodulation. Anesth Analg 82:187–204
-
(1996)
Anesth Analg
, vol.82
, pp. 187-204
-
-
Landers, D.F.1
Hill, G.E.2
Wong, K.C.3
-
38
-
-
0032521823
-
Transfusion-induced immunomodulation following cancer surgery: fact or fiction?
-
COI: 1:CAS:528:DyaK1cXivFGjsbc%3D, PID: 9554439
-
Lapierre V, Auperin A, Tiberghien P (1998) Transfusion-induced immunomodulation following cancer surgery: fact or fiction? J Natl Cancer Inst 90:573–580
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 573-580
-
-
Lapierre, V.1
Auperin, A.2
Tiberghien, P.3
-
39
-
-
84897537450
-
Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis
-
COI: 1:CAS:528:DC%2BC2cXmtVaqsLo%3D, PID: 24691607
-
Rohde JM, Dimcheff DE, Blumberg N et al (2014) Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 311:1317–1326
-
(2014)
JAMA
, vol.311
, pp. 1317-1326
-
-
Rohde, J.M.1
Dimcheff, D.E.2
Blumberg, N.3
-
40
-
-
0027467636
-
Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells
-
COI: 1:STN:280:DyaK3s3hsVSnsQ%3D%3D, PID: 8461473
-
Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP (1993) Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 81:1880–1882
-
(1993)
Blood
, vol.81
, pp. 1880-1882
-
-
Blajchman, M.A.1
Bardossy, L.2
Carmen, R.3
Sastry, A.4
Singal, D.P.5
-
41
-
-
0022513856
-
Association between transfusion of whole blood and recurrence of cancer
-
COI: 1:STN:280:DyaL2s%2FgtFWmtQ%3D%3D
-
Blumberg N, Heal JM, Murphy P et al (1986) Association between transfusion of whole blood and recurrence of cancer. Br Med J 293:530–533
-
(1986)
Br Med J
, vol.293
, pp. 530-533
-
-
Blumberg, N.1
Heal, J.M.2
Murphy, P.3
-
42
-
-
84864042696
-
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
-
PID: 22513904
-
Carson JL, Carless PA, Hebert PC (2012) Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 4:CD002042
-
(2012)
Cochrane Database Syst Rev
, vol.4
, pp. 002042
-
-
Carson, J.L.1
Carless, P.A.2
Hebert, P.C.3
-
43
-
-
1842715067
-
Feasibility of a restrictive red-cell transfusion policy for patients treated with chemotherapy for acute myeloid leukaemia
-
COI: 1:STN:280:DC%2BD2c7lt1CitA%3D%3D, PID: 15043591
-
Jansen AJ, Caljouw MA, Hop WC, van Rhenen DJ, Schipperus MR (2004) Feasibility of a restrictive red-cell transfusion policy for patients treated with chemotherapy for acute myeloid leukaemia. Transfus Med 14:33–38
-
(2004)
Transfus Med
, vol.14
, pp. 33-38
-
-
Jansen, A.J.1
Caljouw, M.A.2
Hop, W.C.3
van Rhenen, D.J.4
Schipperus, M.R.5
-
44
-
-
84892980199
-
Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review
-
COI: 1:CAS:528:DC%2BC3sXhvFyru7jO, PID: 24331453
-
Salpeter SR, Buckley JS, Chatterjee S (2014) Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 127:124–131
-
(2014)
Am J Med
, vol.127
, pp. 124-131
-
-
Salpeter, S.R.1
Buckley, J.S.2
Chatterjee, S.3
-
45
-
-
84864758825
-
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation
-
PID: 22592695
-
Estcourt L, Stanworth S, Doree C et al (2012) Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 5:CD004269
-
(2012)
Cochrane Database Syst Rev
, vol.5
, pp. 004269
-
-
Estcourt, L.1
Stanworth, S.2
Doree, C.3
-
46
-
-
84877624763
-
A no-prophylaxis platelet-transfusion strategy for hematologic cancers
-
COI: 1:CAS:528:DC%2BC3sXnvVWls7k%3D, PID: 23656642
-
Stanworth SJ, Estcourt L, Powter G et al (2013) A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 368:1771–1780
-
(2013)
N Engl J Med
, vol.368
, pp. 1771-1780
-
-
Stanworth, S.J.1
Estcourt, L.2
Powter, G.3
|